Bellerophon Therapeutics Company

Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.


Connections from

Funding Status: IPO
Headquarters: Warren, New Jersey, United States
Founded Date: 2009
Investor Type: N/A
Investment Stage: N/A
Technology: Cancer
Employee Number: 11-50
Number Of Exists: N/A
Estimated Revenue: $1M to $10M
Industry: PharmTech